Published: Dec 17, 2020
CAMBRIDGE, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) Spero Therapeutics Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, today announced the appointment of Satyavrat “Sath” Shukla, CFA, as Chief Financial Officer, effective as of January 4, 2021.
“Sath is an ideal fit for our management team given his experience leading financial strategy and executing within both clinical and commercial stage companies,” said Ankit Mahadevia, M.D., Chief Executive Officer of Spero Therapeutics. “He has extensive strategic and financial expertise, which will be instrumental in helping us to drive corporate growth through the potential commercialization of tebipenem HBr and the clinical advancement of SPR720 and SPR206. We are excited to welcome Sath to Spero and are eager to
Share:
VANCOUVER, British Columbia, Dec. 15, 2020 (GLOBE NEWSWIRE)
Integra Resources Corp. ( Integra or the Company ) (TSXV:ITR, NYSE:ITRG) announces that it has granted a total of 285,683 options, 358,203 restricted share units and 87,500 deferred share units (together the Equity Incentive Awards ) to various employees, executives, directors and consultants of the Company. The Equity Incentive Awards have been granted pursuant to the Company s Equity Incentive Plan and are subject to vesting provisions. The options have an exercise price of $4.71 per share and will expire five years from the date of grant.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Rogue Corporate Update: AGM Results, Sales Growth Continues in Landscape Stone, Update Call in January marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.
Rogue Resources Inc.: Rogue Corporate Update: AGM Results, Sales Growth Continues in Landscape Stone, Update Call in January
Rogue Stone s ramp-up continued at the Bobcaygeon and Orillia quarries, with strong fall sales
August-September-October sold 7,993 tons realizing $80/ton with direct expenses of $39/ton
Rogue declared Commercial Production on September 1
st and filed a two-month Income Statement
A Corporate Update conference call will be held with investors on Tuesday, January 12th, 2021 at 12:00pm EST
TORONTO, ON / ACCESSWIRE / December 15, 2020 / Rogue Resources Inc. (TSXV:RRS) ( Rogue or the Company ) is pleased to announce results of voting at its annual general meeting of shareholders, which was held virtually on December 15, 2020. As permitted by the Notice and Access provisions of the Canadian securities administrators, the Company s Notice of Meeting and Information Circular ( Circular ) was made available on the Company s website and on SEDAR and was not mail
Assure Holdings Announces Results of Annual General and Special Meeting of Shareholders
DENVER, Dec. 11, 2020 Assure Holdings Corp. (the “
Company” or “
Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (
IONM), is pleased to announce that it held its first virtual annual general and special meeting of shareholders (the “
Meeting”) yesterday and that all matters submitted to the shareholders of the Company for approval as set out in the Company’s management information circular dated December 9, 2020 (the “
Circular”), were approved by the requisite majority of votes cast at the Meeting, including:
Electing all nominees to the board of directors of the Company, including Martin Burian, John Farlinger, Preston Parsons, Christopher Rumana, and Steven Summer.